PH25365A - Rhase l inhibitor as a marker for virus infections - Google Patents
Rhase l inhibitor as a marker for virus infectionsInfo
- Publication number
- PH25365A PH25365A PH36551A PH36551A PH25365A PH 25365 A PH25365 A PH 25365A PH 36551 A PH36551 A PH 36551A PH 36551 A PH36551 A PH 36551A PH 25365 A PH25365 A PH 25365A
- Authority
- PH
- Philippines
- Prior art keywords
- rhase
- marker
- inhibitor
- virus infections
- infections
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13697887A | 1987-12-23 | 1987-12-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH25365A true PH25365A (en) | 1991-05-13 |
Family
ID=22475294
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH36551A PH25365A (en) | 1987-12-23 | 1988-02-24 | Rhase l inhibitor as a marker for virus infections |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0325018A3 (fr) |
| JP (1) | JP2690493B2 (fr) |
| KR (1) | KR890010562A (fr) |
| CN (1) | CN1043569A (fr) |
| AU (2) | AU1256488A (fr) |
| CA (1) | CA1337277C (fr) |
| DK (1) | DK112988A (fr) |
| FI (1) | FI880960L (fr) |
| HU (1) | HU205460B (fr) |
| IL (1) | IL85577A0 (fr) |
| NO (1) | NO880935L (fr) |
| OA (1) | OA08815A (fr) |
| PH (1) | PH25365A (fr) |
| PT (1) | PT86880B (fr) |
| RU (1) | RU1836101C (fr) |
| SU (1) | SU1687035A3 (fr) |
| ZA (1) | ZA881470B (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5278042A (en) * | 1989-02-06 | 1994-01-11 | The United States Of America As Represented By The Department Of Health & Human Services | Method for detecting inhibitors of tat protein |
| FR2725214A1 (fr) * | 1994-09-30 | 1996-04-05 | Inst Nat Sante Rech Med | Nouveaux composes utilisables pour la preparation d'agents anti-infectieux |
| US5985565A (en) * | 1996-10-09 | 1999-11-16 | Temple University-Of The Commonwealth System Of Higher Education | Chronic fatigue syndrome diagnosis |
| US6506559B1 (en) | 1997-12-23 | 2003-01-14 | Carnegie Institute Of Washington | Genetic inhibition by double-stranded RNA |
| CN101818145A (zh) | 1998-03-20 | 2010-09-01 | 联邦科学和工业研究组织 | 控制基因表达 |
| AUPP249298A0 (en) | 1998-03-20 | 1998-04-23 | Ag-Gene Australia Limited | Synthetic genes and genetic constructs comprising same I |
| CA2361201A1 (fr) | 1999-01-28 | 2000-08-03 | Medical College Of Georgia Research Institute, Inc. | Composition et methode destinees a l'attenuation in vivo et in vitro de l'expression genique utilisant de l'arn double brin |
| US6207366B1 (en) | 1999-04-14 | 2001-03-27 | Temple University- Of The Commonwealth System Of Higher Education | Chronic fatigue syndrome diagnosis |
| US6423885B1 (en) | 1999-08-13 | 2002-07-23 | Commonwealth Scientific And Industrial Research Organization (Csiro) | Methods for obtaining modified phenotypes in plant cells |
| CA2369944A1 (fr) | 2001-01-31 | 2002-07-31 | Nucleonics Inc. | Utilisation de l'inhibition genetique post-transcriptionnelle pour identifier les sequences d'acides nucleiques qui modulent la fonction d'une cellule |
| CN112088903A (zh) * | 2020-09-28 | 2020-12-18 | 武汉愔紫生物科技有限公司 | 一种大分子蛋白在抗菌抗病毒消毒剂中的应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2505845A1 (fr) * | 1981-05-13 | 1982-11-19 | Choay Sa | Procede de dosage de la 2',5'-oligo-adenylate-synthetase, methodes de detection d'une infection virale ou microbienne, de dosage de la concentration de l'interferon circulant ou present dans des tissus, apres administration de l'interferon, ou apres administration d'inducteurs de l'interferon et ensemble pret a l'emploi, ou kit, pour la mise en oeuvre desdits procedes de dosage et methodes de detection et de dosage |
| EP0113162B1 (fr) * | 1982-09-16 | 1989-07-19 | Hem Research, Inc. | Effet antinéoplastiques des acides ds-ribonucléiques sur les cellules des tumeurs |
| CA1326450C (fr) * | 1985-08-26 | 1994-01-25 | William A. Carter | Modulation des manifestations associees au virus du sida au moyen d'arn a double brin |
-
1988
- 1988-02-24 PH PH36551A patent/PH25365A/en unknown
- 1988-02-29 CA CA000560051A patent/CA1337277C/fr not_active Expired - Fee Related
- 1988-02-29 IL IL85577A patent/IL85577A0/xx not_active IP Right Cessation
- 1988-03-02 ZA ZA881470A patent/ZA881470B/xx unknown
- 1988-03-02 NO NO88880935A patent/NO880935L/no unknown
- 1988-03-02 DK DK112988A patent/DK112988A/da not_active Application Discontinuation
- 1988-03-02 PT PT86880A patent/PT86880B/pt not_active IP Right Cessation
- 1988-03-02 HU HU881015A patent/HU205460B/hu not_active IP Right Cessation
- 1988-03-02 FI FI880960A patent/FI880960L/fi not_active Application Discontinuation
- 1988-03-02 AU AU12564/88A patent/AU1256488A/en not_active Abandoned
- 1988-03-02 EP EP88301820A patent/EP0325018A3/fr not_active Withdrawn
- 1988-03-02 JP JP63047657A patent/JP2690493B2/ja not_active Expired - Fee Related
- 1988-03-03 OA OA59295A patent/OA08815A/xx unknown
- 1988-03-03 KR KR1019880002189A patent/KR890010562A/ko not_active Ceased
- 1988-03-03 SU SU884355467A patent/SU1687035A3/ru active
- 1988-03-03 CN CN88101696A patent/CN1043569A/zh active Pending
- 1988-10-26 RU SU884356721A patent/RU1836101C/ru active
-
1992
- 1992-05-12 AU AU16187/92A patent/AU660973B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| FI880960A7 (fi) | 1989-06-24 |
| DK112988A (da) | 1989-06-24 |
| OA08815A (en) | 1989-03-31 |
| HUT47745A (en) | 1989-03-28 |
| AU1618792A (en) | 1992-09-10 |
| KR890010562A (ko) | 1989-08-09 |
| NO880935L (no) | 1989-06-26 |
| PT86880A (pt) | 1988-04-01 |
| CN1043569A (zh) | 1990-07-04 |
| RU1836101C (ru) | 1993-08-23 |
| FI880960A0 (fi) | 1988-03-02 |
| AU1256488A (en) | 1989-06-29 |
| AU660973B2 (en) | 1995-07-13 |
| SU1687035A3 (ru) | 1991-10-23 |
| HU205460B (en) | 1992-04-28 |
| JP2690493B2 (ja) | 1997-12-10 |
| DK112988D0 (da) | 1988-03-02 |
| EP0325018A3 (fr) | 1990-01-17 |
| FI880960L (fi) | 1989-06-24 |
| CA1337277C (fr) | 1995-10-10 |
| NO880935D0 (no) | 1988-03-02 |
| ZA881470B (en) | 1988-11-18 |
| IL85577A0 (en) | 1988-08-31 |
| JPH01171500A (ja) | 1989-07-06 |
| EP0325018A2 (fr) | 1989-07-26 |
| PT86880B (pt) | 1993-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB8925876D0 (en) | Marker | |
| JPS6429365A (en) | Dopamine-beta-hydroxylase inhibitor | |
| PH25365A (en) | Rhase l inhibitor as a marker for virus infections | |
| EP0420804A3 (en) | Anthelmintic compounds | |
| EP0420805A3 (en) | Anthelmintic compounds | |
| GB8824636D0 (en) | Tie marker | |
| GB8902409D0 (en) | Aliphatic compounds | |
| GB9016290D0 (en) | Improved magazine for clay targets | |
| GB2217643B (en) | Line marker | |
| IE880586L (en) | RNase L INHIBITOR AS MARKER FOR AIDS | |
| GB8917416D0 (en) | Masonry marker | |
| CA60475S (en) | Marker | |
| AU100347S (en) | Direction marker | |
| GB8717844D0 (en) | Markers | |
| GB8726071D0 (en) | Marker arrangement | |
| CS862387A1 (en) | Smesny inhibitor koroze oceli | |
| CS25787A1 (en) | Inhibitor koroze | |
| AU101207S (en) | A marker | |
| IL83693A0 (en) | Assay for virus infections | |
| ZA886709B (en) | Marker devices | |
| GB8909878D0 (en) | Inhibitor | |
| AU104259S (en) | Marker case | |
| GB9002883D0 (en) | Euro marker | |
| GB8726892D0 (en) | Antipilferage tag/marker | |
| AU7420287A (en) | Non-antibiotic marker system |